AR109858A1 - METHODS THAT USE HDAC11 INHIBITORS - Google Patents
METHODS THAT USE HDAC11 INHIBITORSInfo
- Publication number
- AR109858A1 AR109858A1 ARP170102934A ARP170102934A AR109858A1 AR 109858 A1 AR109858 A1 AR 109858A1 AR P170102934 A ARP170102934 A AR P170102934A AR P170102934 A ARP170102934 A AR P170102934A AR 109858 A1 AR109858 A1 AR 109858A1
- Authority
- AR
- Argentina
- Prior art keywords
- hdac11
- inhibitors
- methods
- patient
- diseases
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title abstract 3
- 108091005772 HDAC11 Proteins 0.000 title 1
- 102100039385 Histone deacetylase 11 Human genes 0.000 title 1
- 102000043270 Histone deacetylase 11 Human genes 0.000 abstract 3
- 108700038332 Histone deacetylase 11 Proteins 0.000 abstract 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 3
- 201000010099 disease Diseases 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000002062 proliferating effect Effects 0.000 abstract 1
- 230000035755 proliferation Effects 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente provee métodos y usos de inhibidores de histona desacetilasa 11 (HDAC11) en el tratamiento de enfermedades y/o trastornos, como, por ejemplo, enfermedades proliferativas celulares. Reivindicación 1: Un método para inhibir o reducir la proliferación de células cancerosas en un paciente que lo necesita, que comprende administrarle un inhibidor de HDAC11 al paciente.This provides methods and uses of histone deacetylase 11 (HDAC11) inhibitors in the treatment of diseases and / or disorders, such as, for example, cell proliferative diseases. Claim 1: A method of inhibiting or reducing the proliferation of cancer cells in a patient in need, comprising administering an HDAC11 inhibitor to the patient.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662410766P | 2016-10-20 | 2016-10-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR109858A1 true AR109858A1 (en) | 2019-01-30 |
Family
ID=65351696
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP170102934A AR109858A1 (en) | 2016-10-20 | 2017-10-20 | METHODS THAT USE HDAC11 INHIBITORS |
Country Status (1)
| Country | Link |
|---|---|
| AR (1) | AR109858A1 (en) |
-
2017
- 2017-10-20 AR ARP170102934A patent/AR109858A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX383484B (en) | METHOD FOR TREATING CANCER. | |
| MX2021013830A (en) | Ezh2 inhibitors for treating lymphoma. | |
| MX2016007351A (en) | COMBINATION THERAPY TO TREAT CANCER. | |
| PH12017500070A1 (en) | Methods of treating cancer using tigit inhibitors and anti-cancer agents | |
| MX2018002344A (en) | Method for treating cancer. | |
| MX382902B (en) | NOTH PATHWAY INHIBITOR IN COMBINATION WITH AN IMMUNOTHERAPEUTIC AGENT FOR USE IN THE TREATMENT OF CANCER. | |
| DOP2017000268A (en) | METHODS AND KITS TO TREAT DEPRESSION | |
| CR20150217A (en) | HISTONE DEMETILASE INHIBITORS | |
| WO2016025635A3 (en) | Combination therapy for treating cancer | |
| NI201600051A (en) | COMBINATIONS OF HISTONE DESACETILASE INHIBITORS AND IMMUNOMODULATING DRUGS | |
| MX391720B (en) | COMBINATION THERAPY TO TREAT CANCER. | |
| MX383866B (en) | EZH2 INHIBITORS FOR TREATMENT OF LYMPHOMAS. | |
| CR20190394A (en) | AUTOTAXIN INHIBITOR COMPOUNDS(Divisional de Exp. 2016-0289) | |
| MX2019010601A (en) | Combination therapy for treating cancer. | |
| MX374452B (en) | GLUCOSYLCERAMIDE SYNTHASE INHIBITORS FOR THE TREATMENT OF DISEASES. | |
| MX2015010791A (en) | Methods of treating cancer and preventing drug resistance. | |
| WO2016043874A3 (en) | Combination therapy for treating cancer | |
| ECSP16008797A (en) | DERIVATIVES OF HETEROBICICLOARIL AS RORC2 INHIBITORS AND METHODS OF USE OF THE SAME | |
| MX374749B (en) | COMBINATION THERAPY INCLUDING A TOR KINASE INHIBITOR AND A CYTIDINE ANALOGUE TO TREAT CANCER. | |
| BR112017026535A2 (en) | compound of formula I, isolated enantiomer, pharmaceutical composition, method for inhibiting mct4 monocarboxylate transporter activity, method for selectively inhibiting mct4 monocarboxylate transporter activity, method for treating a mct4 monocarboxylate transporter mediated disorder and use of a compound | |
| BR112017018198A2 (en) | inhibition of olig2 activity | |
| MX2019013862A (en) | Combination therapy. | |
| BR112018068027A2 (en) | method for treating cancer in a patient and pharmaceutical composition | |
| MX394015B (en) | INHIBITION OF OLIG2 ACTIVITY. | |
| BR112016016901A2 (en) | agents for use in the treatment of retinal inflammation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |